Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, United States
Disclosure information not submitted.
SUN-708 - Type 2 Diabetes Mellitus, Central Obesity and Low HDL Are Independent and Additive Risk Predictors of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with F2-F3 Fibrosis; A Large Liver Biopsy Based Study
Sunday, June 14, 20269:00 AM - 4:00 PM CT